Actively Recruiting
Evaluating the Validity and Reliability of the Turkish Heat Sensitivity Scale in People Aged 40 to 85 with Parkinsons Disease
Led by Acibadem University · Updated on 2026-07-22
100
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the Turkish version of the Heat Sensitivity Scale in individuals with Parkinsons disease. This cross-sectional observational study aims to examine the scales validity and reliability, including its internal consistency, test-retest reliability, and construct validity. The goal is to provide a trustworthy tool for assessing temperature sensitivity in Turkish-speaking people diagnosed with Parkinsons disease aged 40 to 85. Participants will complete assessments that include the Heat Sensitivity Scale and the Parkinsons Disease Questionnaire-39 PDQ-39. These measurements will be taken at baseline to evaluate their psychometric properties. No interventions or treatments are administered as part of this observational study. During the study, participants will attend assessments at the Movement Disorders Outpatient Clinic, where cognitive and communication abilities will be evaluated to ensure they can complete the questionnaires. Researchers will measure the Heat Sensitivity Scale total score and PDQ-39 total and subscale scores at the time of questionnaire completion. The study spans from May 2026 to May 2027, with the primary outcome measured at baseline.
CONDITIONS
Brief Title
"Turkish Validity and Reliability of the Heat Sensitivity Scale for Individuals With Parkinson's Disease"
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of Parkinson's disease
- Hoehn and Yahr stage 1-3
- Age between 40 and 85 years
- Mini-Mental State Examination score ≥ 24
- Sufficient cognitive and communication ability to complete the assessments
- Attendance at the Movement Disorders Outpatient Clinic of the Neurology Department
- Willingness to participate and provide written informed consent
You will not qualify if you...
- Presence of a major psychiatric disorder such as major depressive disorder or a psychotic disorder
- Diagnosis of advanced dementia
- Presence of an uncontrolled systemic chronic disease such as uncontrolled diabetes mellitus or hypertension
- Presence of a severe cardiovascular or respiratory condition
- Presence of an additional orthopedic or neurological condition that may affect assessment performance
- Severe visual or hearing impairment that may interfere with the assessments
- Inability to cooperate adequately during the assessments
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here